Emergent BioSolutions Inc.
EBS
$8.07
-$0.06-0.74%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 205.40M | 245.50M | 267.30M | 149.10M | 99.50M |
| Total Receivables | 84.20M | 149.50M | 79.80M | 203.70M | 154.50M |
| Inventory | 343.40M | 356.30M | 338.60M | 314.00M | 311.70M |
| Prepaid Expenses | 25.80M | 25.60M | 24.00M | 30.20M | 26.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.70M | 10.00M | 9.80M | 9.80M | 6.10M |
| Total Current Assets | 662.50M | 786.90M | 719.50M | 706.80M | 598.70M |
|
|
|||||
| Total Current Assets | 662.50M | 786.90M | 719.50M | 706.80M | 598.70M |
| Net Property, Plant & Equipment | 216.00M | 217.00M | 223.80M | 227.60M | 282.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 436.50M | 452.70M | 469.00M | 485.20M | 501.50M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.60M | 4.40M | 4.80M | 6.50M | 7.20M |
| Total Assets | 1.32B | 1.46B | 1.42B | 1.43B | 1.39B |
|
|
|||||
| Total Accounts Payable | 55.60M | 57.40M | 63.70M | 58.10M | 60.90M |
| Total Accrued Expenses | 54.00M | 50.50M | 45.10M | 37.90M | 73.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.40M | 1.80M | 1.80M | 1.90M | 2.70M |
| Total Finance Division Other Current Liabilities | 20.20M | 26.80M | 16.50M | 14.00M | 25.00M |
| Total Other Current Liabilities | 20.20M | 26.80M | 16.50M | 14.00M | 25.00M |
| Total Current Liabilities | 132.20M | 136.50M | 127.10M | 111.90M | 162.40M |
|
|
|||||
| Total Current Liabilities | 132.20M | 136.50M | 127.10M | 111.90M | 162.40M |
| Long-Term Debt | 572.10M | 663.10M | 667.80M | 665.70M | 663.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.20M | 6.10M | 6.50M | 5.10M | 9.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 82.50M | 72.80M | 79.50M | 90.70M | 71.10M |
| Total Liabilities | 796.00M | 878.50M | 880.90M | 873.40M | 906.90M |
|
|
|||||
| Common Stock & APIC | 942.50M | 938.70M | 935.30M | 930.90M | 928.10M |
| Retained Earnings | -159.80M | -105.20M | -156.40M | -144.40M | -212.40M |
| Treasury Stock & Other | -260.10M | -251.00M | -242.70M | -233.80M | -232.90M |
| Total Common Equity | 522.60M | 582.50M | 536.20M | 552.70M | 482.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 522.60M | 582.50M | 536.20M | 552.70M | 482.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 522.60M | 582.50M | 536.20M | 552.70M | 482.80M |
|
|
|||||